Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19332456 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)
Condition: Renal Failure
Interventions: Drug: 10mg Rosuvastatin;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.